Copyright
©The Author(s) 2024.
World J Cardiol. Dec 26, 2024; 16(12): 720-730
Published online Dec 26, 2024. doi: 10.4330/wjc.v16.i12.720
Published online Dec 26, 2024. doi: 10.4330/wjc.v16.i12.720
Table 1 Baseline characteristics of the nonpulmonary arterial hypertension and pulmonary arterial hypertension patients
Variables | Total number | nonPAH | PAH | P value |
Number | 69 | 18 | 51 | - |
Sex, number of males | 69 | 7 (38.9) | 21 (41.2) | 0.866 |
Age in months | 69 | 8.5 (5.4, 12.0) | 11.0 (7.0,19.0) | 0.094 |
BMI | 68 | 15.4 (13.8, 17.4) | 15.1 (14.1, 16.6) | 0.451 |
Creatinine in μmol/L | 68 | 21.8 (18.0, 26.5) | 27.8 (24.3, 33.6) | < 0.001 |
BUN in mmol/L | 68 | 3.0 (2.1, 3.7) | 4.2 (2.8, 5.1) | 0.015 |
Albumin in g/L | 67 | 42.6 (39.6, 43.7) | 43.5 (41.4, 45.3) | 0.243 |
Glucose in mmol/L | 65 | 4.6 (4.1, 5.0) | 4.1 (3.8, 4.4) | 0.036 |
Hemoglobin in g/L | 69 | 116 (101, 123) | 118 (108, 128) | 0.448 |
Platelets as 109/L | 69 | 276 (247, 314) | 267 (221, 344) | 0.995 |
White blood cells as 109/L | 46 | 8.3 (5.7, 9.7) | 8.7 (7.5, 11.0) | 0.140 |
SBP in mmHg | 66 | 93.0 (84.5, 95.0) | 95.0 (86.5, 101.5) | 0.144 |
DBP in mmHg | 66 | 55.0 (48.5, 60.0) | 55.0 (45.0, 60.0) | 0.860 |
EF as % | 67 | 65.0 (62.0, 66.3) | 65.0 (65.0, 69.5) | 0.072 |
Diameter in mm | 66 | 10.0 (7.5, 13.0) | 10.0 (8.0, 14.8) | 0.219 |
mPAP in mmHg | 69 | 17.7 (16.7, 18.8) | 29.4 (24.6, 40.1) | < 0.001 |
LCN2 in ng/mL | 69 | 19.3 (16.9, 27.6) | 33.4 (23.9, 46.3) | < 0.001 |
ET1 in μg/mL | 69 | 0.14 (0.07, 0.31) | 0.30 (0.10, 0.72) | 0.049 |
Table 2 Correlations of mean pulmonary artery pressure, lipocalin-2 and endothelin-1 with clinical variables
Variables | mPAP | LCN2 | ET-1 | |||
r | P value | r | P value | r | P value | |
Sex | 0.087 | 0.475 | 0.031 | 0.800 | -0.115 | 0.347 |
Age in months | 0.298 | 0.013 | 0.319 | 0.008 | 0.048 | 0.698 |
BMI | -0.089 | 0.483 | -0.128 | 0.310 | -0.248 | 0.046 |
Creatinine in μmol/L | 0.389 | 0.001 | 0.094 | 0.446 | -0.156 | 0.205 |
BUN in mmol/L | 0.328 | 0.006 | -0.040 | 0.747 | -0.070 | 0.568 |
Albumin in g/L | 0.066 | 0.594 | -0.072 | 0.563 | -0.238 | 0.052 |
Glucose in mmol/L | -0.174 | 0.166 | 0.021 | 0.869 | -0.004 | 0.973 |
Hemoglobin in g/L | 0.217 | 0.074 | 0.080 | 0.514 | -0.173 | 0.156 |
Platelets as 109/L | 0.007 | 0.958 | -0.128 | 0.293 | -0.098 | 0.422 |
White blood cells as 109/L | 0.345 | 0.019 | 0.291 | 0.050 | 0.107 | 0.480 |
SBP in mmHg | 0.135 | 0.280 | 0.074 | 0.554 | 0.033 | 0.795 |
DBP in mmHg | 0.097 | 0.438 | 0.106 | 0.399 | 0.003 | 0.983 |
EF as % | -0.107 | 0.388 | -0.176 | 0.155 | -0.021 | 0.864 |
Diameter in mm | 0.371 | 0.002 | 0.081 | 0.516 | 0.230 | 0.063 |
mPAP in mmHg | - | - | 0.544 | < 0.001 | 0.508 | < 0.001 |
LCN2 in ng/mL | 0.544 | < 0.001 | - | - | 0.427 | < 0.001 |
ET1 in μg/mL | 0.508 | < 0.001 | 0.427 | < 0.001 | - | - |
Table 3 Multivariate logistic regression analysis to define the correlation between lipocalin-2 and renal function in ventricular septal defect patients
Variables | Creatinine1 | BUN1 | ||||
OR | 95%CI | P value | OR | 95%CI | P value | |
Age in months | 1.077 | 1.006-1.153 | 0.034 | 1.117 | 1.010-1.235 | 0.031 |
BMI | 1.226 | 0.913-1.648 | 0.175 | - | - | - |
Albumin in g/L | 1.089 | 0.901-1.315 | 0.378 | 1.016 | 0.837-1.232 | 0.875 |
Glucose in mmol/L | - | - | - | 0.635 | 0.294-1.371 | 0.248 |
Hemoglobin in g/L | - | - | - | 1.042 | 0.992-1.094 | 0.102 |
mPAP in mmHg | 1.065 | 0.992-1.142 | 0.082 | 1.086 | 1.008-1.170 | 0.030 |
LCN2 in ng/mL | 0.962 | 0.914-1.014 | 0.147 | 0.972 | 0.922-1.025 | 0.294 |
Table 4 Univariate logistic regression analysis to determine the related factors of pulmonary arterial hypertension and lipocalin-2
Variables | Correlation with PAH | Correlation with LCN21 | ||||
OR | 95%CI | P value | OR | 95%CI | P value | |
Sex, males | 1.1 | 0.366-3.303 | 0.865 | 1.212 | 0.463 ± 3.172 | 0.696 |
Age in months | 1.05 | 0.985-1.119 | 0.137 | 1.050 | 1.002 ± 1.101 | 0.043 |
BMI | 0.868 | 0.669-1.127 | 0.289 | 0.859 | 0.676 ± 1.091 | 0.213 |
Creatinine in μmol/L | 1.204 | 1.066-1.359 | 0.003 | 1.021 | 0.952 ± 1.094 | 0.566 |
BUN in mmol/L | 1.684 | 1.089-2.606 | 0.019 | 0.967 | 0.711 ± 1.316 | 0.832 |
Albumin in g/L | 1.114 | 0.942-1.317 | 0.205 | 1.050 | 0.930 ± 1.186 | 0.432 |
Glucose in mmol/L | 0.648 | 0.346-1.213 | 0.175 | 0.763 | 0.431 ± 1.350 | 0.353 |
Hemoglobin in g/L | 1.017 | 0.982-1.053 | 0.345 | 1.006 | 0.977 ± 1.036 | 0.686 |
Platelets as 109/L | 1 | 0.995-1.006 | 0.887 | 0.999 | 0.995 ± 1.004 | 0.841 |
White blood cells as 109/L | 1.259 | 0.960-1.651 | 0.096 | 1.111 | 0.908 ± 1.361 | 0.306 |
SBP in mmHg | 1.036 | 0.984-1.091 | 0.176 | 1.018 | 0.977 ± 1.060 | 0.401 |
DBP in mmHg | 0.998 | 0.955-1.044 | 0.944 | 1.027 | 0.983 ± 1.073 | 0.239 |
EF as % | 1.099 | 0.966-1.250 | 0.152 | 0.932 | 0.834 ± 1.040 | 0.207 |
Diameter in mm | 1.106 | 0.944-1.296 | 0.211 | 1.011 | 0.883 ± 1.157 | 0.877 |
mPAP in mmHg | - | - | - | 1.084 | 1.026 ± 1.145 | 0.004 |
LCN2 in ng/mL | 1.107 | 1.033-1.185 | 0.004 | - | - | - |
ET-1 in μg/mL | 10.028 | 0.896-112.196 | 0.061 | 2.101 | 0.887 ± 4.979 | 0.092 |
Table 5 Multivariate logistic regression analysis to define the correlation between endothelin-1 concentration and risk for pulmonary arterial hypertension
Variables | OR (95%CI) | P value |
Age in months | 0.994 (0.914-1.081) | 0.889 |
Creatinine in μmol/L | 1.232 (1.056-1.436) | 0.008 |
Diameter in mm | 0.984 (0.811-1.195) | 0.871 |
ET-1 in μg/mL | 9.681 (0.650-144.192) | 0.099 |
Table 6 Predictive values of lipocalin-2 and endothelin-1 for pulmonary arterial hypertension
AUC | Youden’s index | Sensitivity, % | Specificity, % | Cutoff value | |
LCN2 | 0.783 | 0.4575 | 90.19 | 55.56 | 19.42 ng/mL |
ET-1 | 0.657 | 0.3954 | 45.10 | 94.44 | 0.39 μg/mL |
Table 7 Correlations of post-repair mean pulmonary artery pressure with clinical variables, n = 23
Variables | Post-operative mPAP | mPAP decrease | ||
r | P value | r | P value | |
Sex, male | 0.404 | 0.056 | 0.303 | 0.161 |
Age in months | 0.347 | 0.105 | 0.434 | 0.039 |
BMI | -0.141 | 0.531 | -0.050 | 0.826 |
Creatinine in μmol/L | -0.150 | 0.493 | 0.248 | 0.255 |
BUN in mmol/L | 0.236 | 0.278 | 0.411 | 0.052 |
Albumin in g/L | 0.313 | 0.156 | 0.029 | 0.897 |
Glucose in mmol/L | -0.045 | 0.849 | -0.057 | 0.813 |
Hemoglobin in g/L | 0.223 | 0.306 | 0.163 | 0.458 |
Platelets as 109/L | -0.066 | 0.764 | 0.107 | 0.628 |
White blood cells as 109/L | 0.186 | 0.507 | 0.623 | 0.013 |
SBP in mmHg | 0.094 | 0.677 | 0.043 | 0.848 |
DBP in mmHg | 0.361 | 0.099 | 0.185 | 0.410 |
EF as % | -0.311 | 0.148 | -0.037 | 0.867 |
Diameter in mm | 0.398 | 0.060 | 0.552 | 0.006 |
Pre-repair mPAP in mmHg | 0.471 | 0.023 | 0.883 | < 0.001 |
LCN2 in ng/mL | 0.532 | 0.009 | 0.181 | 0.407 |
ET-1 in μg/mL | 0.140 | 0.523 | 0.298 | 0.167 |
- Citation: Guo ZK, Chen PG, Li YX, Jiao H, Kong XH, Bai S, Li XF, Liu AJ, Wang GL. Independent prognostic value of lipocalin-2 in congenital heart disease-associated pulmonary artery hypertension. World J Cardiol 2024; 16(12): 720-730
- URL: https://www.wjgnet.com/1949-8462/full/v16/i12/720.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i12.720